[1] World Health Organization. WHO coronavirus (COVID-19) dashboard. 2023. https://covid19.who.int/. [2023-2-14].
[2] Willyard C. How quickly does COVID immunity fade? What scientists know. Nature 2023;614(7948):395 − 6. http://dx.doi.org/10.1038/D41586-023-00124-Y.
[3] Cao YL, Jian FC, Wang J, Yu YL, Song WL, Yisimayi A, et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature 2023;614(7948):521 − 9. http://dx.doi.org/10.1038/S41586-022-05644-7.
[4] Oxford Martin School. Our world in data. 2023. https://ourworldindata.org/covid-vaccinations. [2023-3-3].
[5] World Bank. World bank open data. 2023. https://data.worldbank.org/. [2023-2-28].
[6] Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou FF. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther 2022;7(1):141. http://dx.doi.org/10.1038/s41392-022-00997-x.
[7] Lei H, Yang L, Wang G, Zhang C, Xin YT, Sun QR, et al. Transmission patterns of seasonal influenza in China between 2010 and 2018. Viruses 2022;14(9):2063. http://dx.doi.org/10.3390/v14092063.
[8] Ryu S, Han C, Ali ST, Achangwa C, Yang BY, Pei S. Association of public health and social measures on the hand-foot-mouth epidemic in South Korea. J Infect Public Health 2023;16(6):859 − 64. http://dx.doi.org/10.1016/j.jiph.2023.03.029.
[9] Baker RE, Yang WC, Vecchi GA, Metcalf CJE, Grenfell BT. Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic. Science 2020;369(6501):315 − 9. http://dx.doi.org/10.1126/science.abc2535.
[10] The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020. China CDC Wkly 2020;2(8):113 − 22. http://dx.doi.org/10.46234/ccdcw2020.032.
[11] Han C, Seo H, Cho S, Chiara A, Ryu S. Impact of travel restrictions for travellers from China on the internal spread of SARS-CoV-2 in South Korea. J Travel Med 2023;taad047. http://dx.doi.org/10.1093/jtm/taad047.